Successful ICU Care of a 14-Year-Old With Total Artificial Circulation Using Two Ventricular Assist Devices for 118 Days

Richard Silverman, Sean M. Quinn

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Within the first year following orthotopic heart transplantation, the patient is at risk of graft failure, rejection, and infection. Late mortality is often due to allograph vasculopathy. Most of the patients with primary graft failure will usually recover with temporary mechanical ventricular assist support; however, on occasion the patient must be retransplanted. For the patient who suffers primary graft failure necessitating explanation and bridging until a new suitable graft is found, there are several total artificial heart options. However, in the pediatric population these options are limited. The authors' surgical colleagues were able to fashion a paracorporeal total artificial heart constructed with 2 ventricular assist devices. In this case report, the authors discuss a pediatric patient who had to be explanted and supported for an extended amount of time. This article describes the incidence of cardiomyopathy in juvenile rheumatoid arthritis patients, the choice of extracorporeal membrane oxygenation/extracorporeal complete life support versus ventricular assist devices for support, the major causes of primary graft failure, and the authors' experience in caring for an adolescent with such a device for a protracted length of time (118 days).

Original languageEnglish
Pages (from-to)240-246
Number of pages7
JournalICU Director
Volume3
Issue number5
DOIs
StatePublished - Dec 1 2012

Fingerprint

Heart-Assist Devices
Transplants
Artificial Heart
Extracorporeal Membrane Oxygenation
Pediatrics
Juvenile Arthritis
Graft Rejection
Heart Transplantation
Cardiomyopathies
Equipment and Supplies
Mortality
Incidence
Infection
Population

Keywords

  • adolescent
  • heart failure
  • heart transplantation
  • intensive care unit
  • systemic juvenile rheumatic arthritis
  • Thoratec
  • ventricular assist device

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Management Science and Operations Research
  • Critical Care

Cite this

Successful ICU Care of a 14-Year-Old With Total Artificial Circulation Using Two Ventricular Assist Devices for 118 Days. / Silverman, Richard; Quinn, Sean M.

In: ICU Director, Vol. 3, No. 5, 01.12.2012, p. 240-246.

Research output: Contribution to journalArticle

@article{dd0f566b2faa458891064ac2851b016c,
title = "Successful ICU Care of a 14-Year-Old With Total Artificial Circulation Using Two Ventricular Assist Devices for 118 Days",
abstract = "Within the first year following orthotopic heart transplantation, the patient is at risk of graft failure, rejection, and infection. Late mortality is often due to allograph vasculopathy. Most of the patients with primary graft failure will usually recover with temporary mechanical ventricular assist support; however, on occasion the patient must be retransplanted. For the patient who suffers primary graft failure necessitating explanation and bridging until a new suitable graft is found, there are several total artificial heart options. However, in the pediatric population these options are limited. The authors' surgical colleagues were able to fashion a paracorporeal total artificial heart constructed with 2 ventricular assist devices. In this case report, the authors discuss a pediatric patient who had to be explanted and supported for an extended amount of time. This article describes the incidence of cardiomyopathy in juvenile rheumatoid arthritis patients, the choice of extracorporeal membrane oxygenation/extracorporeal complete life support versus ventricular assist devices for support, the major causes of primary graft failure, and the authors' experience in caring for an adolescent with such a device for a protracted length of time (118 days).",
keywords = "adolescent, heart failure, heart transplantation, intensive care unit, systemic juvenile rheumatic arthritis, Thoratec, ventricular assist device",
author = "Richard Silverman and Quinn, {Sean M.}",
year = "2012",
month = "12",
day = "1",
doi = "10.1177/1944451612456702",
language = "English",
volume = "3",
pages = "240--246",
journal = "ICU Director",
issn = "1944-4516",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Successful ICU Care of a 14-Year-Old With Total Artificial Circulation Using Two Ventricular Assist Devices for 118 Days

AU - Silverman, Richard

AU - Quinn, Sean M.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Within the first year following orthotopic heart transplantation, the patient is at risk of graft failure, rejection, and infection. Late mortality is often due to allograph vasculopathy. Most of the patients with primary graft failure will usually recover with temporary mechanical ventricular assist support; however, on occasion the patient must be retransplanted. For the patient who suffers primary graft failure necessitating explanation and bridging until a new suitable graft is found, there are several total artificial heart options. However, in the pediatric population these options are limited. The authors' surgical colleagues were able to fashion a paracorporeal total artificial heart constructed with 2 ventricular assist devices. In this case report, the authors discuss a pediatric patient who had to be explanted and supported for an extended amount of time. This article describes the incidence of cardiomyopathy in juvenile rheumatoid arthritis patients, the choice of extracorporeal membrane oxygenation/extracorporeal complete life support versus ventricular assist devices for support, the major causes of primary graft failure, and the authors' experience in caring for an adolescent with such a device for a protracted length of time (118 days).

AB - Within the first year following orthotopic heart transplantation, the patient is at risk of graft failure, rejection, and infection. Late mortality is often due to allograph vasculopathy. Most of the patients with primary graft failure will usually recover with temporary mechanical ventricular assist support; however, on occasion the patient must be retransplanted. For the patient who suffers primary graft failure necessitating explanation and bridging until a new suitable graft is found, there are several total artificial heart options. However, in the pediatric population these options are limited. The authors' surgical colleagues were able to fashion a paracorporeal total artificial heart constructed with 2 ventricular assist devices. In this case report, the authors discuss a pediatric patient who had to be explanted and supported for an extended amount of time. This article describes the incidence of cardiomyopathy in juvenile rheumatoid arthritis patients, the choice of extracorporeal membrane oxygenation/extracorporeal complete life support versus ventricular assist devices for support, the major causes of primary graft failure, and the authors' experience in caring for an adolescent with such a device for a protracted length of time (118 days).

KW - adolescent

KW - heart failure

KW - heart transplantation

KW - intensive care unit

KW - systemic juvenile rheumatic arthritis

KW - Thoratec

KW - ventricular assist device

UR - http://www.scopus.com/inward/record.url?scp=84875484541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875484541&partnerID=8YFLogxK

U2 - 10.1177/1944451612456702

DO - 10.1177/1944451612456702

M3 - Article

VL - 3

SP - 240

EP - 246

JO - ICU Director

JF - ICU Director

SN - 1944-4516

IS - 5

ER -